DaVita HealthCare Partners Stock Market Value
| DVA Stock | USD 151.85 -3.18 -2.05% |
| Symbol | DaVita |
Quarterly Earnings Growth 6.5% | Earnings Share 9.5 | Revenue Per Share | Quarterly Revenue Growth 9.9% | Return On Assets |
For DaVita HealthCare, market value and book value represent two distinct lenses on the same underlying business. DaVita HealthCare's market capitalization is 10.22 B. At P/B 21.63, DaVita HealthCare trades at a significant premium to book value. Enterprise value stands at 22.4 B. Where intrinsic value falls relative to market price and book value helps frame the analytical picture.
For DaVita HealthCare, intrinsic value is a model-driven estimate while price is a market-driven observation. For DaVita HealthCare, key inputs include a P/E ratio of 11.43, a P/B ratio of 21.63, a profit margin of 4.58%, and ROE of -109.0%.
What-If Analysis
Backtesting a what-if scenario on DaVita HealthCare Partners shows how the stock may have behaved if the position had been entered, held, or resized under different historical assumptions. The analytical value is perspective: it shows whether the thesis would have remained investable across different historical windows or depended too heavily on one favorable stretch.
| 01/24/2026 |
| 04/24/2026 |
A 0.00 position in DaVita HealthCare initiated on January 24, 2026 and held to today would realize 0.00 in aggregate gains. The change equals a 0.0% return on investment in DaVita HealthCare for the period over a 90 day window. The competitive set for DaVita HealthCare includes Ensign, Align Technology, Universal Health, AptarGroup, Bio Rad, Chemed Corp, and Molina Healthcare. DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure More
Upside and Downside Indicators for DaVita HealthCare Dashboard
Upside and downside indicators for DaVita HealthCare summarize momentum balance and potential range context for the stock. The signals capture how recent price action aligns with observed directional ranges.
| Downside Deviation | 1.88 | |||
| Information Ratio | 0.1784 | |||
| Maximum Drawdown | 26.79 | |||
| Value At Risk | -3.13 | |||
| Potential Upside | 3.95 |
DaVita HealthCare Market Risk Indicators Overview
DaVita HealthCare market risk signals reflect the scope and pattern of historical return variability. Each indicator reflects observed variability across the available data window.| Risk Adjusted Performance | 0.1769 | |||
| Jensen Alpha | 0.5799 | |||
| Total Risk Alpha | 0.5834 | |||
| Sortino Ratio | 0.3083 | |||
| Treynor Ratio | -2.44 |
Statistical evidence for mean reversion in DaVita HealthCare's appears through its tendency to revert after extreme valuations. Under mean reversion theory, DaVita HealthCare's price extremes are viewed as temporary dislocations that may self-correct.
Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1769 | |||
| Market Risk Adjusted Performance | -2.43 | |||
| Mean Deviation | 1.89 | |||
| Semi Deviation | 1.56 | |||
| Downside Deviation | 1.88 | |||
| Coefficient Of Variation | 552.02 | |||
| Standard Deviation | 3.26 | |||
| Variance | 10.61 | |||
| Information Ratio | 0.1784 | |||
| Jensen Alpha | 0.5799 | |||
| Total Risk Alpha | 0.5834 | |||
| Sortino Ratio | 0.3083 | |||
| Treynor Ratio | -2.44 | |||
| Maximum Drawdown | 26.79 | |||
| Value At Risk | -3.13 | |||
| Potential Upside | 3.95 | |||
| Downside Variance | 3.55 | |||
| Semi Variance | 2.44 | |||
| Expected Short fall | -2.35 | |||
| Skewness | 3.89 | |||
| Kurtosis | 24.31 |
DaVita HealthCare Backtested Returns
DaVita HealthCare suggests a very low volatility profile over the observed timeframe. It has a Sharpe Ratio of 0.18, which indicates that 0.18 units of return per unit of risk over the last 3 months. We identified twenty-nine technical indicators supporting this volatility profile. Please assess metrics such as mean deviation of 1.89, market risk-adjusted performance of -2.43, and Downside Deviation of 1.88 to evaluate statistical risk alignment. On a scale of 0 to 100, DaVita HealthCare holds a performance score of 14. The firm maintains a Beta of -0.24, which signifies very low measured sensitivity to broad market movements. The mildly negative beta suggests DaVita HealthCare provides a partial hedge against market-wide declines.
Auto-correlation | -0.21 |
Weak reverse predictability
The autocorrelation profile for DaVita HealthCare Partners registers weak reverse predictability between the two measured intervals. When lagged price patterns show consistency, they can serve as a partial input for modeling DaVita HealthCare's near-term price behavior. A serial correlation of -0.21 indicates that over 21.0% of current DaVita HealthCare price fluctuations can be explained by its historical price movements. Given that DaVita HealthCare Partners has negative autocorrelation for the selected time horizon, market participants may evaluate potential contrarian price behavior over comparable future intervals.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 7.09 |